Resources

Instant Insights – CRISPR

Home | Resources

Prescriber Perceptions around CRISPR in 2023

Four years ago, InCrowd assessed the awareness among physicians of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.
In considering the 2019 research, InCrowd wanted to understand any change in awareness of these therapies and then examine specific perceptions around CRISPR. This research reflects the comparisons of awareness between 2019 and 2023 of nucleic acid-based therapies with a specific focus on CRISPR.

Our 2023 report includes responses from over 100 qualified US-based healthcare professionals (HCPs) familiar with the therapies considered in the research.

Explore respondents’:

  • Awareness of CRISPR and mRNA
  • Optimism and concerns regarding the widespread use of CRISPR
  • Comfort level recommending and administering CRISPR to patients

Get our key takeaways. Download the report today.

Please fill out the form below to access this content

Related Resources

Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more
ASH 2023 Post-Event Round-Up 

ASH 2023 Post-Event Round-Up 

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...

read more
Dobbs Decision After 18-Months 

Dobbs Decision After 18-Months 

HCP Perspectives 1 ½ Years After Dobbs v. Jackson Women’s Health Organization Our new Instant Insights report delves into the aftermath of the Dobb's decision, examining its impact on patients and healthcare professionals. Our objectives were threefold: Explore the...

read more